Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer

Figure 5

Inner validation of the risk model. Patients were random divided into two validation sets at a ratio of 5 : 5. The maximum AUC values of 5 years exceed over 0.8 in two validation sets ((a) and (b)). The maximum inflection point is the cut-off point ((c) and (d)). One year, three years, and five years AUV value were exhibited, respectively ((e) and (f)).

(a)

(b)

(c)

(d)

(e)

(f)